Skip to main content
Clinical Trials/DRKS00018351
DRKS00018351CompletedNot Applicable

Validity of device-internal AHI detection during OSA therapy with regard to its application in telemonitoring - Tele-AHI

Fachkrankenhaus Kloster Grafschaft GmbH0 sites136 target enrollmentStarted: February 12, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
136

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Polysomnographic or polygraphic control of a device based sleep apnoea therapy with devices of the types AirSense 10 Autoset, AirSense 10 Elite, AirSense 10 Autoset for Her, SOMNObalance, SOMNOsoft 2 oder prismaSMART

Exclusion Criteria

  • Mask leakage >25L/min, therapy duration during recording time <4h, if a nasal mask was used: mouth leakage time >10% of therapy duration

Investigators

Similar Trials

Validity of device-internal AHI detection... | Clinical Trial